Figure 4From: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial Subjects reporting >50% decrease in abdominal pain (“Responders”). RP-G28 (n = 36). Placebo (n = 19). Subjects with no abdominal pain at baseline were excluded from the analysis. p = 0.0288.Back to article page
